Dixon Hughes Goodman Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$32K	Hold	249	–	–	0.01%	366
2021 Q4	$38K	Buy	+249	New	+$38.6K	0.01%	286

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's IBB Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q1 2022 at 249 shares worth $32K. The position accounts for 0.01% of the portfolio, ranked #366.

Dixon Hughes Goodman Wealth Advisors first reported a position in IBB in Q4 2021 and has held it in 2 quarters since. The position peaked at $38K in Q4 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 249 shares of iShares Biotechnology ETF worth $32K as of Q1 2022.
Dixon Hughes Goodman Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q1 2022.
iShares Biotechnology ETF made up 0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #366 holding.
Dixon Hughes Goodman Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 2 quarters since.
Dixon Hughes Goodman Wealth Advisors's iShares Biotechnology ETF position peaked at $38K in Q4 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.